Risk Groups of Developing Active Tuberculosis in Liver Transplant Recipients in a Tuberculosis Endemic Area: Risk Stratification by Chest Image and Interferon Gamma Release Assay. (December 2021)
- Record Type:
- Journal Article
- Title:
- Risk Groups of Developing Active Tuberculosis in Liver Transplant Recipients in a Tuberculosis Endemic Area: Risk Stratification by Chest Image and Interferon Gamma Release Assay. (December 2021)
- Main Title:
- Risk Groups of Developing Active Tuberculosis in Liver Transplant Recipients in a Tuberculosis Endemic Area: Risk Stratification by Chest Image and Interferon Gamma Release Assay
- Authors:
- Kim, Si-Ho
Oh, Suhyun
Nham, Eliel
Ko, Jae-Hoon
Huh, Kyungmin
Cho, Sun Young
Kang, Cheol-In
Chung, Doo Ryeon
Choi, Gyu-Seong
Kim, Jong Man
Joh, Jae-Won
Peck, Kyong Ran - Abstract:
- Highlights: We analyzed factors that may predict active TB in liver transplantation recipients. IGRA positivity itself was not associated with TB development in a TB-endemic area. IGRA positive predicted active TB when chest images suggested a previous TB infection. Both IGRA and chest CT should be considered to identify LTBI treatment candidates. Abstract: Objectives: We implemented a stratified risk analysis to predict the development of active tuberculosis (TB) in liver transplantation (LT) recipients based on IGRA and chest images in a TB-endemic area. Methods: In this retrospective cohort study, LT recipients who tested for IGRA between May 2008 and December 2017 were included. Chest images compatible with old TB lesions were considered as positive images. LT recipients were divided into six groups: LT recipients with history of treated TB, image (+)/IGRA (+), image (+)/IGRA (-), image (-)/IGRA (+), image (-)/IGRA (-) and LTBI treated. The Cox regression model was used to analyze risk groups. Results: Among the 717 eligible LT recipients included in this study, 21 patients developed active TB. Incidence rates of TB were 2, 261, 724, and 119 cases/100, 000 person-years in the 1st, 2nd, and ≥ 3rd year after transplantation, respectively. History of treated TB (HR 18.92; 95% CI 4.10–87.25) and image (+)/IGRA (+) (HR 10.86; 95% CI 2.75–42.89) were independent risk factors for developing active TB. IGRA (+) with a negative image was not a risk factor. Conclusions: OurHighlights: We analyzed factors that may predict active TB in liver transplantation recipients. IGRA positivity itself was not associated with TB development in a TB-endemic area. IGRA positive predicted active TB when chest images suggested a previous TB infection. Both IGRA and chest CT should be considered to identify LTBI treatment candidates. Abstract: Objectives: We implemented a stratified risk analysis to predict the development of active tuberculosis (TB) in liver transplantation (LT) recipients based on IGRA and chest images in a TB-endemic area. Methods: In this retrospective cohort study, LT recipients who tested for IGRA between May 2008 and December 2017 were included. Chest images compatible with old TB lesions were considered as positive images. LT recipients were divided into six groups: LT recipients with history of treated TB, image (+)/IGRA (+), image (+)/IGRA (-), image (-)/IGRA (+), image (-)/IGRA (-) and LTBI treated. The Cox regression model was used to analyze risk groups. Results: Among the 717 eligible LT recipients included in this study, 21 patients developed active TB. Incidence rates of TB were 2, 261, 724, and 119 cases/100, 000 person-years in the 1st, 2nd, and ≥ 3rd year after transplantation, respectively. History of treated TB (HR 18.92; 95% CI 4.10–87.25) and image (+)/IGRA (+) (HR 10.86; 95% CI 2.75–42.89) were independent risk factors for developing active TB. IGRA (+) with a negative image was not a risk factor. Conclusions: Our findings suggested that both IGRA and chest images should be considered to identify risk groups for LTBI treatment. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 113(2021)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 113(2021)
- Issue Display:
- Volume 113, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 113
- Issue:
- 2021
- Issue Sort Value:
- 2021-0113-2021-0000
- Page Start:
- 359
- Page End:
- 366
- Publication Date:
- 2021-12
- Subjects:
- Tuberculosis -- Latent tuberculosis infection -- Liver transplantation -- Interferon-gamma release assay -- Chest image
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2021.10.043 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20070.xml